GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » Short Interest

DaShenLin Pharmaceutical Group Co (SHSE:603233) Short Interest


View and export this data going back to 2017. Start your Free Trial

What is DaShenLin Pharmaceutical Group Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of DaShenLin Pharmaceutical Group Co's Short Interest

For the Biotechnology subindustry, DaShenLin Pharmaceutical Group Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaShenLin Pharmaceutical Group Co's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DaShenLin Pharmaceutical Group Co's Short Interest distribution charts can be found below:

* The bar in red indicates where DaShenLin Pharmaceutical Group Co's Short Interest falls into.



DaShenLin Pharmaceutical Group Co (SHSE:603233) Business Description

Traded in Other Exchanges
N/A
Address
No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Headlines

No Headlines